Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al.
Neuro-Oncology · 2024
DOI: 10.1093/neuonc/noad239 ↗Kurz gefasst
Editorial in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Rong-Zong Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada.
ORCID-Profile: Roseline Godbout
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Liu, R. Z., Choi, W. S., & Godbout, R. (2024). Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad239
Vancouver
Liu RZ, Choi WS, Godbout R. Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al. Neuro-Oncology. 2024. doi:10.1093/neuonc/noad239
BibTeX
@article{Liu2024,
author = {Liu, Rong-Zong and Choi, Won-Shik and Godbout, Roseline},
title = {Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al},
journal = {Neuro-Oncology},
year = {2024},
doi = {10.1093/neuonc/noad239}
}
EUVIMED